BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Weinstein AA, de Avila L, Paik J, Golabi P, Escheik C, Gerber L, Younossi ZM. Cognitive Performance in Individuals With Non-Alcoholic Fatty Liver Disease and/or Type 2 Diabetes Mellitus. Psychosomatics 2018;59:567-74. [DOI: 10.1016/j.psym.2018.06.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Cheon SY, Song J. Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation. Cell Biosci 2022;12:99. [DOI: 10.1186/s13578-022-00836-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kang S, Kim E, Cho H, Kim DJ, Kim HC, Jung SJ. Associations between non-alcoholic fatty liver disease and cognitive impairment and the effect modification of inflammation. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-16788-x] [Reference Citation Analysis]
3 Gairing SJ, Schleicher EM, Labenz C. Diabetes mellitus - risk factor and potential future target for hepatic encephalopathy in patients with liver cirrhosis? Metab Brain Dis 2022. [PMID: 36001211 DOI: 10.1007/s11011-022-01068-4] [Reference Citation Analysis]
4 Kouvari M, Sergi D, D’cunha N, Bulman A, Panagiotakos D, Naumovski N. Is Non-Alcoholic Fatty Liver Disease Connected with Cognition? The Complex Interplay between Liver and Brain. Diabetology 2022;3:355-363. [DOI: 10.3390/diabetology3020026] [Reference Citation Analysis]
5 Basu E, Mehta M, Zhang C, Zhao C, Rosenblatt R, Tapper EB, Parikh NS. Association of chronic liver disease with cognition and brain volumes in two randomized controlled trial populations. J Neurol Sci 2022;434:120117. [PMID: 34959080 DOI: 10.1016/j.jns.2021.120117] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ballester M, Gallego J, Fiorillo A, Casanova-ferrer F, Giménez-garzó C, Escudero-garcía D, Tosca J, Ríos M, Montón C, Durbán L, Ballester J, Benlloch S, Urios A, San-miguel T, Kosenko E, Serra M, Felipo V, Montoliu C. Metabolic syndrome is associated with poor response to rifaximin in minimal hepatic encephalopathy. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-06416-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Chen M, Wang J, Zhou S, Zhang C, Deng D, Liu F, Luo W, Zhu J, Yu Y. Brain Structure as a Correlate of Odor Identification and Cognition in Type 2 Diabetes. Front Hum Neurosci 2022;16:773309. [DOI: 10.3389/fnhum.2022.773309] [Reference Citation Analysis]
8 Liu Q, Liu C, Hu F, Deng X, Zhang Y. Non-alcoholic Fatty Liver Disease and Longitudinal Cognitive Changes in Middle-Aged and Elderly Adults. Front Med 2022;8:738835. [DOI: 10.3389/fmed.2021.738835] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Kapfhammer H. Erkrankungen von Leber und Pankreas. Depression, Angst, traumatischer Stress und internistische Erkrankungen 2022. [DOI: 10.1007/978-3-662-65873-4_7] [Reference Citation Analysis]
10 Lampignano L, Donghia R, Griseta C, Lagravinese G, Sciarra S, Zupo R, Castellana F, Bortone I, Guerra V, Tirelli S, De Nucci S, Tatoli R, Lozupone M, Sborgia G, Leo A, De Pergola G, Giannelli G, Panza F, Sardone R. Liver Health and Dementia in an Italian Older Population: Findings From the Salus in Apulia Study. Front Aging Neurosci 2021;13:748888. [PMID: 34955810 DOI: 10.3389/fnagi.2021.748888] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
11 Giménez-Garzó C, Fiorillo A, Ballester-Ferré MP, Gallego JJ, Casanova-Ferrer F, Urios A, Benlloch S, Martí-Aguado D, San-Miguel T, Tosca J, Ríos MP, Montón C, Durbán L, Escudero-García D, Aparicio L, Felipo V, Montoliu C. A New Score Unveils a High Prevalence of Mild Cognitive Impairment in Patients with Nonalcoholic Fatty Liver Disease. J Clin Med 2021;10:2806. [PMID: 34202269 DOI: 10.3390/jcm10132806] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
12 Garg K, Brackett S, Hirsch IB, Garg SK. NAFLD/NASH and Diabetes. Diabetes Technol Ther 2020;22:S174-86. [PMID: 32069155 DOI: 10.1089/dia.2020.2513] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Kjærgaard K, Mikkelsen ACD, Wernberg CW, Grønkjær LL, Eriksen PL, Damholdt MF, Mookerjee RP, Vilstrup H, Lauridsen MM, Thomsen KL. Cognitive Dysfunction in Non-Alcoholic Fatty Liver Disease-Current Knowledge, Mechanisms and Perspectives. J Clin Med 2021;10:673. [PMID: 33572481 DOI: 10.3390/jcm10040673] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
14 Klein C, Adamek HE. Auch unter Typ-1-Diabetikern verbreitet. Info Diabetol 2021;15:17-18. [DOI: 10.1007/s15034-020-3640-6] [Reference Citation Analysis]
15 Parikh NS, Kumar S, Rosenblatt R, Zhao C, Cohen DE, Iadecola C, Kamel H. Association between liver fibrosis and cognition in a nationally representative sample of older adults. Eur J Neurol 2020;27:1895-903. [DOI: 10.1111/ene.14384] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
16 Zhou Y, Zhang T, Lee D, Yang L, Li S. Body mass index across adult life and cognitive function in the American elderly. Aging (Albany NY) 2020;12:9344-53. [PMID: 32413871 DOI: 10.18632/aging.103209] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
17 Gehrke N, Schattenberg JM. Metabolic Inflammation-A Role for Hepatic Inflammatory Pathways as Drivers of Comorbidities in Nonalcoholic Fatty Liver Disease? Gastroenterology 2020;158:1929-1947.e6. [PMID: 32068022 DOI: 10.1053/j.gastro.2020.02.020] [Cited by in Crossref: 81] [Cited by in F6Publishing: 83] [Article Influence: 27.0] [Reference Citation Analysis]
18 Huang Z, Wu LM, Zhang JL, Sabri A, Wang SJ, Qin GJ, Guo CQ, Wen HT, Du BB, Zhang DH, Kong LY, Tian XY, Yao R, Li YP, Liang C, Li PC, Wang Z, Guo JY, Li L, Dong JZ, Zhang YZ. Dual Specificity Phosphatase 12 Regulates Hepatic Lipid Metabolism Through Inhibition of the Lipogenesis and Apoptosis Signal-Regulating Kinase 1 Pathways. Hepatology 2019;70:1099-118. [PMID: 30820969 DOI: 10.1002/hep.30597] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 8.5] [Reference Citation Analysis]
19 Younossi ZM, Golabi P, Henry L. A Comprehensive Review of Patient-reported Outcomes in Patients With Chronic Liver Diseases. J Clin Gastroenterol 2019;53:331-41. [PMID: 30702486 DOI: 10.1097/MCG.0000000000001179] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]